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Abstract 
 
The study conducted here was to investigate the gene and protein expression of Toll like receptor 
9 when human bronchial epithelial cells were induced by lipopolysaccharide. TLRs are pattern 
recognition receptor (PRR) which plays a key role in innate immunity. They recognise the 
molecules that are shared by pathogens but distinguishes from the host which is referred to as 
pathogen associated molecular patterns (PAMPs). The HBECs were first cultured and once it 
becomes confluent they were induced with 10ng/ml of LPS. In order to find out whether the gene 
was expressed in the cells, the RNA was isolated and RT-PCR was carried out. Before carrying 
out the RT-PCR, RNA gel electrophoresis was carried out to show the 28S and 18S bands. Once 
the gene expression was analysed protein expression was carried out by extracting the protein 
using RIPA buffer and running the SDS-PAGE followed by staining. Silver staining and western 
blotting results revealed clear bands at 116kDa illustrating that the TLR9 protein had been 
expressed. RT-PCR results showed that a smear of bands for TLR9 and the in protein expression 
bands were seen in TLR9 protein region which indicates that TLR9 was expressed in the HBEC 
by LPS.   
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1. Introduction 
 
The aim of the study was to know whether Toll like receptor 9 (TLR9) is expressed when the 
human bronchial epithelial cells were induced with Lipopolysaccharide. The gene and protein 
expression analysis were made in this study. 
1.1 An brief introduction on the immunity and immune response 
 
Immunity refers to all the mechanism involved in the organism for the protection of body against 
pathogens such as bacteria, fungi, viruses, and wide range of foreign substances. Any foreign 
substance that is capable of inducing the immune response and in the production of antibodies is 
called as immunogens. Foreign substances, microbes or foreign particles that are capable of 
interacting with the immune system products are called as antigens. All antigens have the ability 
to bind to its respective antibody but they may not have the immunogenic capacity (ability to 
induce immune response). There are various types of immunity of which overview of two basic 
types are discussed namely, acquired and innate immunity. The immunity due to the exposure of 
various antigens is called acquired immunity which will produce immunological memory (Hunt 
2007).These are non-specific immunity which is the first line defence system and doesn’t 
produce immunological memory ( Hunt 2007). 
 
1.2 TLR – Toll like receptors  
 
1.2.1 What are TLR’s? 
Toll like receptors are type I transmembrane proteins characterized by an extracellular leucine-
rich domain and a cytoplasmic domain. Since they have a homolog with the cytoplasmic domain 
of the Interleukin1 receptor (IL-1R) they are referred to as Toll/IL-1R domain or TIR domain. 
They belong to pattern recognition receptor (PRR) which plays a key role in innate immunity. 
They recognise the molecules that are shared by pathogens but distinguishes from the host which 
is referred to as pathogen associated molecular patterns (PAMPs). 
 
1.2.2 Structure of TLRs 
 
The common structure for the mammalian TLR family has the following features: multiple 
leucine-rich repeats and one or two cysteine-rich regions in the large and different ligand-binding 
ectodomain; a short transmembrane region; and has a highly homologous conserved cytoplasmic 
domain among the individual TLRs. As the cytoplasmic domain of the interleukin 1 receptor (IL-
1R) TLRs also possess a similar one Toll/IL-1R (TIR) domain (Laurent et al 2005). 
 
1.3 Different types of TLR’s and their respective ligands 
 
1.3.1 TLRs Types 
 
These belong to the TLRs family and identify pathogen associated molecular pattern which is 
specific for gram-positive bacteria. TLRs encode a protein which recognizes the pathogen and 
activates the innate immunity. Both the human and drosophila TLR are highly conserved and 
shares the structural and functional similarities. TLR 1 mediate the production of cytokines by 
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recognizing the pathogen associated molecular patterns (PAMPs) expressed in the pathogen. 
There are thirteen classes of human TLRs have been found so far identified TLR (1-13).  
 
1.3.2 Ligands of TLRs 
 
The TLR family members are used as critical signal transducers by some pathogen-associated 
molecular patterns and host-derived products. The LPS from Gram-negative bacteria is essential 
for TLR 4 signalling; the LPS from Leptospira and P. gingivalis are recognized by the TLR 2 
and not by TLR 4. The endogenous host-derived products, such as hsp60 and fragments from 
fibronectin are also identified by TLR 4. TLR 5 recognizes flagellin and TLR 9 CpG DNA for 
signalling. (Akira et al., 2001). 
 
1.4 Role of TLR in innate immunity  
TLRs can induce the production of different types of cytokines such as IL-12 and IL-18 in 
antigen presenting cells (APCs) when they recognize the pathogens or their products. The 
cytokines that are produced will function as a useful cytokines to force naive T cells to 
differentiate into TH1 cells. Pathogens are usually captured in multiple ways like phagocytosis, 
endocytosis or via TLRs themselves and the pathogens captured are then processed & presented 
to T cells as major histocompatibility complex−antigen (Ito et al 2002). Antigen presentation 
requires connected up-regulated expression of co stimulatory molecules on the cell surface of 
APCs for expansion of antigen-specific T cell clones, which is also triggered by TLR signaling. 
The role TLR-stimulated APCs do is mainly inducing TH1 development and it still remains 
unclear whether they are involved in TH2 development. (Akira et al., 2001).  
1.5 Signalling pathway of TLR 
TLRs facilitates dimerization with other TLRs when it recognises the microbes i.e., TLR2 is 
shown to form heterophilic dimer with TLR1 and TLR6 in some case they are believed to form 
homodimers. The dimerization activates the signalling pathways which originate from the 
cytoplasmic TIR domain. For the induction of inflammatory cytokines such as TNF-α & IL-12 
through all TLRs MyD88 (myeloid differentiation primary-response protein 88- a TIR domain 
containing adaptor) is essential. The gene expression use to be slightly different for specific TLR 
activation, which indicates that signaling pathway is divergent although MyD88 is common 
implies there are MyD88-dependent and MyD88-independent pathways (Muzio et al., 2000). 
When TLRs are triggered it associates with the MyD88, allowing the association of IRAK1 (IL-
1R-associated kinase 1) by recruiting IRAK4. Phosphorylation of IRAK1 is then induced by 
IRAK4, phosphorylated IRAK1 associates with the TRAF6 (tumour-necrosis-factor-receptor-
associated factor 6). Phosphorylated IRAK1 and TRAF6 forms a complex with TAK1 
(transforming-growth-factor- -activated kinase), TAB1 (TAK1-binding protein 1) and TAB2 at 
the plasma membrane inducing the phosphorylation of TAB2 and TAK1 (Akira & Takeda 2004).  
A complex consisting of TRAF6, TAK1, TAB1 and TAB2 translocates to the cytosol, when 
IRAK1 is degrades at the plasma membrane. The complex then associates with ubiquitin ligases 
UBC13 (ubiquitin-conjugating enzyme 13) and UEV1A (ubiquitin-conjugating enzyme E2 
variant 1), leading to the ubiquitylation of TRAF6. TAK1 gets activated by the ubiquilated 
TRAF6, activated TAK1 phosphorylates both mitogen-activated protein (MAP) kinases and the 
4 
 
IKK complex (inhibitor of nuclear factor- B (I B)-kinase complex), which consists of IKK- , 
IKK-  and IKK-  (also called as IKK1, IKK2 and nuclear factor- B (NF- B) essential 
modulator, NEMO, respectively). The translocation of NF- B to nucleus for the induction of the 
specific gene occurs when IKK complex phosphorylates I B leading to the ubiquitylation and 
subsequent degradation (Akira et al., 2004). 
 
1.6 MyD88 Dependent pathway 
Study on MyD88-deficient cells shown the existence of MyD88-dependent and -independent 
pathways, both of which intervene signalling in response to LPS. For example for the TLR2 
(mycoplasmal lipopeptide) ligand the activation of NF- B is completely abolished when 
MyD88-deficient macrophages, in case of TLR4 (LPS) ligand the response is observed with 
delayed kinetics. It’s also noted that MAPK activation is delayed in LPS-stimulated MyD88-
deficient macrophages (Akira & Takeda; 2004).  
 
1.7 MyD88 Independent Pathway 
The (IFN)-regulatory factor (IRF3) will be activated in MyD88-independent pathway activates 
which will lead to the production of IFN-ß and the expression of IFN-inducible genes. According 
to the MYD88 independent pathway the TLR molecules activates the Interferon Regulatory 
Factor (IRF-3) that in hand induces the interferon – β synthesis. The interferon molecule 
produced in the cytoplasm reaches the extracellular matrix and self activates the other co-
stimulatory genes for interferon production in the cell through stat 1 molecule. It also involve in 
the late phase and leads IFN-ß production & IFN-inducible genes expression (Akira & Takeda 
2004). 
 
1.8 Role of TLR9 in triggering innate and adaptive immunity 
Irrespective of presence or absence of CpG motifs, DNA is endocytosed into the cellular 
compartment where it is exposed to TLR9, which is activated if the DNA contains CpG motifs. 
Activation of TLR9, in pDC is dependent on interleukin (IL)-1 receptor-associated kinase 
(IRAK)-4 and interferon regulatory factor-7(IRF7), and requires direct interactions between 
IRF7 and MyD88, tumour-necrosis factor-α(TNF- α) receptor activated factor-6 (TRAF6) and 
IRAK-1. Activation of TLR9 results in induction of nuclear factor-κB(NF-κB) and other 
intracellular signalling pathways that trigger a rapid innate immune response which is 
characterized by the secretion of a variety of proinflammatory and antiviral cytokines, such as 
IL-6,  TNFα and type 1 interferon’s(IFN), and immune regulatory cytokines that limit the 
intensity of the inflammatory response, such as IL-10. There is also a converse effect of CpG-
activated B cells on dendritic cells, by which TLR9 activation drives CD5 B cells to produce IL-
10, which then suppresses the TH1-priming function of the dendritic cells. In contrast to some 
other innate immune responses, relatively little IL-12 is produced by TLR9-activated human 
immune cells.  Secondary activation of Natural killer (NK) cells and other innate immune cells is 
done by pDC through both IFN-dependent and independent pathways. B cells activated through 
TLR9 have a greatly increased sensitivity to antigen stimulation, promoting their differentiation 
to antibody-secreting plasma cells, and therefore contributing to the adaptive immune response 
(Marshall et al., 2003). TLR9 stimulated pDC migrate to the T-Cell zones of lymph nodes and 
other secondary lymphoid tissues where it  express increased levels of co-stimulatory molecules 
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that enhance their capacity to activate naïve and memory T cells, and have increased capacity to 
cross-present soluble protein antigens to CD8 T cells. As a result, CpG DNA promotes strong 
TH1 CD4 and CD8 T-cell responses (Kreig et al 2006). 
 
2.  Materials and Methods 
 
2.1 Cell culture 
 
Cells were cultured using DMEM media which was obtained from the invitrogenTM and the 
media were altered by mixing 45ml of fetal bovine serum (FBS), 5ml of penicillin-Streptomycin 
(1%) to the 500ml DMEM media.  Human bronchial epithelial cells (HBEC) were cultured in the 
T75 flask with the media prepared. The cells were kept in the incubator so as to allow the growth 
and avoid the contamination. The cells were supplied with fresh media for a period of 24 hours 
to allow them grow faster. Once the cells became confluent they were removed from the 
incubator for the process called trypsinization, which was carried out to dissociate the cells in the 
container for the purpose of splitting the confluent cells in the flask into two. The step includes 
the addition of 5 ml trypsin with 45 ml of 1 times PBS to digest the proteins that make the cells 
adhere to the container. One important step in this method is that, when the cells started to float 
the media should be added to the flask to avoid the action of trypsin on the cells. Then the cells 
were induced with the 5ng/ml of LPS for the first time and 10ng/ml of LPS in the second time. 
The concentration was changed in the second time since there was no expression observed at 
5ng/ml. 
 
2.2 Gene expression 
 
2.2.1 RNA Extraction 
 
The confluent cells were lysed by adding RNA STAT-60TM (5ml) by passing the cell lysate 
several times into the flask. Before the addition of the RNA STAT-60TM to the cells it should not 
be washed because of the chance of mRNA degradation. After the process of homogenization the 
homogenate was stored at room temperature so as to permit the complete dissociation of the 
nucleoprotein complexes. 1ml of chloroform added to the RNA STAT-60TM, covered tightly, 
shaken vigorously for 15 to 30 seconds and left at room temperature for 2-3minutes. The 
homogenate was centrifuged at 12,000g to the max for 15 minutes at 40C. Centrifugation 
separated the homogenate into two layers red lower phenol chloroform phase (lower phase) and 
the colourless upper aqueous phase. RNA remains in the aqueous phase whereas the DNA and 
proteins was in the interface and organic phase. The volume of the aqueous phase was about 60-
65% of the volume of the RNA STAT-60TM that was used for homogenization. The upper 
aqueous phase was transferred to a fresh tube and mixed with isopropanol (2.5ml). Samples were 
stored at room temperature for 5-10minutes and centrifuged for 12,000g for 10 minutes at 40C. 
White pellet formed at the bottom of the tube is the RNA precipitate which is often visible before 
centrifugation. Supernatant was removed and the RNA pellet washed once with 75% ethanol by 
vortexing and subsequent centrifugation at 7,500g for 5minutes at 40C. The RNA pellet was 
dried by air-drying or in a vacuum (5-10 min) and it was made sure that it doesn’t get dried up 
completely which might decrease the RNA solubility. RNA pellet was dissolved in 1 mm EDTA 
vortexed and then the pellet was pipette few times. In order for the RNA samples to dissolve they 
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were incubated at 55-600C, for the process of solubilisation RNase-free solutions treated with 
Diethylpyrocarbonate (DEPC) were used in RNA.  
 
2.2.2 Gel Electrophoresis of RNA 
 
1.1% agarose gel was prepared in running buffer.  In a microfuge the alcohol precipitates of 
nucleic acids were centrifuged for five minutes. The tubes were drained thoroughly and 
completely dissolved in the pellet to a concentration of 2 µg/4µl in 10 mM phosphate buffer.  
Two 4 µl aliquots were transferred to polypropylene tubes.  One of the tubes was added with 8 µl 
of phosphate buffer and kept on ice.  To the other 8 µl GFP mix was added and the tubes were 
vortexed and incubated at 55°C for 15 minutes.  To each sample 3 µl of loading mix was added, 
thoroughly mixed, and then loaded with 8 µl on the gel (Barbero et al., 2006).  
 
2.2.3 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
 
The process of synthesis of DNA from an RNA template by means of a reverse transcriptase 
commonly referred to as RT-PCR where RT refers reverse transcription.  
Primers for human TLR9 
Forward primer GGACCTCTGGTACTGCTTCCA 
Reverse Primer AAGCTCGTTGTACACCCAGTCT (Zarember & Godowski 2002) 
First Strand cDNA synthesis  
Contents taken in PCR tube pipette is given in table 1  
The tubes were vortexed gently for 10 seconds to mix the components in the tube and placed in a 
controlled temperature heat block at 480C & incubated for 45minutes. To inactivate the AMV 
reverse transcriptase and to denature the RNA/cDNA/primer it was heated at 940C for 2minutes.   
 
Second Strand cDNA synthesis and PCR amplification 
The PCR tubes were placed in the PCR system and the PCR program was started as mentioned 
in table 2. 2% agarose gel was prepared and in a separate eppendorf tube 1 µl of the PCR 
mixture added with 1 µl of mini gel loading buffer and mixed. The PCR products were loaded to 
the agarose gel and in one lane the DNA molecular weight markers were added and the yield of 
the PCR product estimated.  
 
2.3 Protein Expression 
 
2.3.1 Protein Lysis 
 
RIPA (Radio Immuno Precipitation Buffer) buffer was used for the lysis of the cells from the 
cultured flasks. First the culture medium from the adherent cells in the flask and the cells were 
washed twice with cold PBS (X 1). Cold RIPA buffer was added to the cells and 1ml of the 
buffer and kept on ice for 5 minutes. The plates were swirled for equal spreading of the buffer; 
the cell lysate was collected towards one end of the flask using the cell scraper. Cell lysate was 
transferred to a micro centrifuge tube and centrifuged at ~14,000 X g for 15 minutes to pellet the 
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cell debris. In order to increase the yield the pellets were sonicated for 30 seconds with 50% 
pulse, the supernatant was collected to a new tube for the further process. 
 
2.3.2 SDS-PAGE Gel Electrophoresis 
 
Materials 
 
Acrylamide 30% and Bis acrylamide 0.8% was prepared by mixing 75.0 gram of acrylamide and 
2.0 g of Bis acrylamide and made up to 250 ml using water. Separating Gel Buffer requires 1.875 
M Tris-HCl buffer with pH 8.8 was prepared by mixing 113.5 g of Tris-HCl buffer in 500 ml of 
water and the pH adjusted to 8.8 with HCl. Stacking Gel Buffer includes 0.6 M Tris-HCl buffer 
with pH 6.8 was prepared by mixing 36.6 g of Tris –HCl buffer in 500 ml water and the pH 
adjusted to 6.8 using HCl. Electrode Buffer was made with Tris of 0.05 M (12 g), Glycine of 
0.384 M (5.76 g) and SDS of 0.1% (2 g) was made up to 2 litres using water without any pH 
adjustments. To 5.0 ml of the stacking gel buffer, 0.5 g of SDS, 5.0 g of Sucrose, 0.25 ml of 
Mercaptoethanol and 5.0 ml of Bromophenol Blue of 0.5% is made up to 50 ml using water thus 
the sample buffer was prepared. Ammonium per sulphate 10% (APS) was freshly prepared and 1 
g in 10ml is used.  TEMED (N.N.N`.N`.Tetra methyl ethylene diamine) was provided and 0.1% 
Coomassie Brilliant Blue R250 was mixed in 50% methanol first and then10% glacial acetic acid 
was added to the above mixture for staining purpose. 10% methanol and 7% glacial acetic acid 
was used as a destain solution.  
 
Method 
 
Samples to be run were denatured in the sample buffer by heating for two minutes at a 
temperature range of 95-100°C. Cell homogenates which has to be run was prepared at a final 
concentration of 5-10 mg/ml. The plates were joined to form the cassette after cleaning them 
using methylated spirit and drying. Separating gel was prepared by mixing the following 
components in the same order and quantity the separating gel was prepared. The mixture was 
properly degassed as oxygen will intermit the polymerization of acrylamide and bis acrylamide. 
Table 3 shows the composition of chemicals requires to make a 10 and 15% gels. The gels 
prepared were 7.5% and the half of the 15% gel was taken at a half amount for a litre of solution. 
After degassing 5 l of TEMED was added to the mixture which enables the polymerization 
reaction. Using 1ml Gilson, the separating gel was transferred in to the gel cassette carefully till 
it reaches 0.3 cm from the bottom of the comb. To ensure that the gel sets with a smooth surface, 
distilled water was poured down one edge between the glass plates until a layer of about 2mm 
exists on top of the gel solution and then allowed the gel to get set. Changes in refractive index 
were observed in between the water and the gel. After the gel gets set, water over the separating 
gel was removed with Whatman No. 1 chromatography paper folded over to provide a double 
thickness. The stacking gel was prepared by mixing the following components in the same order 
and quantity the stacking gel was prepared. The mixture was properly degassed as oxygen could 
intermit the polymerization of acrylamide and bis acrylamide, the stacking gel composition was 
taken as shown in table 4. After degassing the stacking gel mixture 5 l of TEMED was added 
and the contents were discharged in to the plates carefully till it reaches the cut away edge of the 
gel plate. Comb of specific size was placed in to the solution of stacking gel in between the 
plates for the well formation. The comb and the spacer below the gel was carefully removed 
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from the gel cast and the gel cassette was placed in the electrophoretic tank. Top reservoir was 
filled with the buffer till it floods over and fills the wells. 300 ml of buffer was added to the 
bottom section cautiously; approximately 5 l of unknown sample and the standards were loaded 
in to the wells slowly. Finally the apparatus was connected to the power pack that produced a 
constant voltage of about 200V. After the gel has completely run, the gel is removed carefully 
from the cassette and then staining was carried out overnight in a shaker. Once the staining was 
over the destaining was done and the bands were observed under transilluminator.  
 
2.3.3 Staining and De-staining 
 
2.3.3.1 Coomassie Staining 
 
The most common staining method for the SDS-PAGE coomassie blue stain was used to view 
the protein bands in the gel. To 50% ,ethanol 0.1% of coomassie brilliant blue R250 was 
dissolved and 10% glacial acetic acid added to the solution. The solution was stirred in a 
magnetic stirrer until the components are mixed thoroughly. After mixing the staining solution 
was added to the gel and for every half an hour the gel was washed with water and the solution 
was replaced. This was followed 3-4 times and left for the overnight in shaker; once the staining 
step was completed destaining was done. In destaining 10% methanol was mixed with 7% acetic 
acid and the solution was added to the stained gel and left for two days. After two days of time 
the gels were viewed in UV light and the bands were photographed for analysis. 
 
2.3.3.2 Silver Staining 
 
The bands obtained in the coomassie blue stain was not so clear hence silver staining was carried 
which is more sensitive than the coomassie blue staining and accurate. The gel was stained with 
silver to obtain clear view of the proteins. Firstly the gel was fixed for 30 minutes in 10% 
glutaraldehyde of 100 cm3 and then the gel was rinsed with distilled water for overnight. Every 
time the water used was changed to obtain good results. After overnight washing the gel was 
soaked in 5 g cm3 of dithiothreitol for 30 minutes. The solution was removed and 0.1% silver 
nitrate was added without rinsing and kept for 30 minutes. After sufficient staining was reached 
the staining was stopped by washing with water.   
 
2.3.3.3 Western Blotting 
 
Western blot is one of the widely used methods for the analysis of the protein expression we 
opted for the use of western blot analysis as a confirmatory test for this protein expression study. 
In general it is method which isolates one protein from a mixture of proteins by means of a 
unique high quality antibody directed towards a particular protein. The method usually involves 
four major steps which are as follows: 
i) The proteins that were obtained from the gel electrophoresis were taken. 
ii) With the use of nitrocellulose paper the gel containing the separated proteins were 
transferred on to it. 
iii) The primary antibody purchased was added to the nitrocellulose paper. 
iv) Secondary antibody was used to make an antibody-enzyme conjugate (Sakudo, 2006; 
Westermeier, 2005). 
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3. Results 
 
3.1 Gene Expression 
 
3.1.1 Gel Electrophoresis of RNA 
 
In order to evaluate the RNA purity and quality, RNA gel electrophoresis was performed (Fig 1). 
Typical 18S and 28S bands were observed in the electrophoretic pattern showed the typical 18S 
and 28S bands which indicate that there was no degradation and no genomic DNA 
contamination. After which the RNA samples were subjected to RT-PCR.  
 
3.1.2 RT-PCR 
 
The RNA samples where amplified as given in the methods and the amplified samples were 
collected from the PCR. Gel was run to know whether the amplified product contains TLR9 in it 
so that it can be confirmed that the gene has been expressed in the cells (Fig 2). In the lanes hunt 
for two TLR’s was done TLR4 and TLR9 and the end of both the lanes the 1Kb markers were 
loaded. 
 
 
3.2 Protein Expression 
 
In order to show that protein was expressed the cells induced by LPS was collected and the 
proteins were extracted as mentioned in the methods. SDS-PAGE was carried out to analyze the 
protein sample. 
 
3.2.1 SDS-PAGE 
 
The SDS-PAGE gels were run at 200V for 40 minutes and once when the samples moves 
towards the other end of the gel they were removed out of the apparatus and stained to view the 
proteins in that.  
 
3.2.1.1 Coomassie blue staining 
 
Staining was done with coomassie blue first to see the proteins in the gel, once the gel was 
stained it was kept for an overnight and destained. (Fig 3) 
 
3.2.1.2 Silver Staining 
 
Since the bands in the coomassie blue stain was not so clear the silver staining was carried out in 
which the bands where very clear showing the respective proteins. (Fig 4) 
 
3.2.1.3 Western Blotting  
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Both the staining tests cannot be taken as a confirmative test western blotting was carried and the 
results of the western blotting showed the clear presence of TLR-9 indicating the induction by 
LPS. (Fig 5)  
 
4.  Discussion 
 
The members of TLR family are expressed on immune cells and play different roles in PAMP 
signalling. Engagement of the TLRs by their respective ligands triggers a multifaceted response 
involving antigen presentation, expression of co stimulatory molecules, and release of cytokines, 
which in turn stimulates adaptive responses involving T and B-lymphocytes. HBEC’s when 
induced with the Lipopolysaccharide showed the gene and protein expression of TLR-9.  
 
4.1 Gene Expression  
 
4.1.1 RNA Analysis  
 
In the gene expression the RNA was first extracted and RNA gel electrophoresis was carried out 
for the 18S and 28S RNA. From the gel electrophoresis results it was clear that there was no 
RNA degradation or any genomic DNA contamination in the sample (Figure 1). Then the cDNA 
was prepared from the RNA samples and amplified using the PCR and the results of the PCR 
showed that the gene was expressed. The result also suggest allows to know the mRNA quality 
since mRNA comprises only 1-3% of total RNA samples and it is not readily detectable even 
with the most sensitive of methods. On the other hand Ribosomal RNA comprises >80% of total 
RNA samples, with the majority of that comprised by the 28S and 18S rRNA species (in 
mammalian systems). Hence the mRNA quality was assessed by electrophoresis of total RNA 
followed by staining with ethidium bromide (Palmer & Prediger, 2008). 
 
4.1.2 Gene expression studies from PCR results 
 
From the PCR results TLR9 was found to be expressed at lower levels (trace amount of bands 
seen in Fig 2), at the same time the amount of other TLR expression was very less compared to 
TLR9. Expression of TLR9 indicates that it has more response compared to the other TLR’s. 
Apart from TLR9, TLR4 response had also been observed at a lower level from the PCR results 
(Figure 2). Clear bands in the region of 312kb indicate that the gene expressed was TLR9 and the 
bands where clearly visible in different kinds of dilutions which were in different lanes. Though 
all the dilution shows a smear of bands the results clearly indicates that the gene was expressed 
hence so to confirm the gene expression the protein expression was also carried out to support 
the report. Previous studies on mice showed that the stimulation with LPS could up regulate gene 
expression of TLR9, indicating that cells with increased TLR9 expression induced by LPS might 
respond to invading bacteria more effectively (An et al., 2002). These results indicate that the 
TLR9 expression has a role with the LPS and from the results shown in fig 2 it is very clear that 
the gene has been expressed by the HBECs when induced with LPS. One other important thing 
to be noted in this experiment is that the TLR were expressed at a high concentration of LPS i.e., 
10ng/ml. At first when 3 and 5ng/ml of LPS were tried the cells dint express the TLR’s which 
indicates that the level of LPS required for the induction of TLR’s may be 10ng/ml. A previous 
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study also indicates that the amount of LPS used for the production of TLR response were 
around 10ng/ml (Jones et al., 2000). 
 
4.2 Protein Expression 
 
4.2.1 SDS-PAGE 
 
Though the results were observed to be a trace in gene expression it was clearly visible that gene 
has been expressed to add more support to this statement protein expression was carried out. In 
the protein expression the proteins were isolated from the cells that were induced by the LPS, 
isolated and run in the SDS-PAGE. Then they were stained with the coomassie blue stain and the 
results showed a band at 116kda in the coomassie blue staining (Figure 3). The band that was 
obtained in the coomassie blue staining was not clearly visible so the gel was stained with silver 
staining. Silver staining is an accurate and sensitive method compared to the coomassie blue 
staining. Hence so the results showed lots of clear bands that were not visible in the coomassie 
blue staining. The bands for TLR9 at 116kda were clearly visible in this staining in two different 
concentrations. The protein expression showed bands that were necessary to show that the gene 
expressed was TLR9 (Figure 4). The western blot results confirms the expression of TLR-9 in 
the HBEC by LPS, which can be shown through the clear bands at 116kDa indicating its 
presence. Finally though the results may show smear of bands in the RT-PCR and silver staining, 
it can be confirmed that the gene or the protein for the TLR9 has been expressed in the cells with 
the results of western blot analysis. Since TLR9 recognize CpG motifs (Akira et al., 2001) which 
was not added to the cells it can be stated that LPS can induce the TLR-9 expression and also 
studies showed that LPS up regulates the TLR9 expression (An et al., 2002). It was shown in a 
study that expression of TLRs in non immune cells may cause autoimmune inflammatory disease 
(Kohn et al., 2005). 
 
5. Conclusion 
 
Thus it can be concluded that the TLR9 can be expressed by lipopolysaccharide which may 
provide a novel approach to the researchers in innate immunity. Studies are being carried out in 
finding out more about the up regulation of the TLR9 expression. It can also be extended in 
finding out the expression of TLRs in non immune cells which results in the expression of an 
autoimmune inflammatory disease for example Hashimoto’s thyroiditis (TLR3 in thyrocytes), 
colitis (TLR4 in intestinal epithelial cells). 
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Figure 1 Showing the Gel Electrophoresis of RNA from the HBECs induced with LPS 
1, 2- RNA Sample showing the 18S and 28S 3-Molecular weight marker 
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Figure 2 showing the RT-PCR results of HBECs for TLR9 gene that was observed 
                1, 18           Molecular weight markers in kilobase pair; 
     2, 3, 4, 5, 6, 7          TLR 4 samples 
10, 11, 12, 13, 14, 15          TLR 9 samples 
 8, 9, 16, 17              No templates 
 
 
 
 
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 showing the band of HBECs for TLR9 protein in the coomassie blue staining  
Lane 1,2,3,4 represents the different concentrations of protein samples and lane 5 represents 
the protein markers in kDa. 
 
 
 
 
 
 
 
1      2     3      4      5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 representing the silver staining results of the human bronchial epithelial cells 
(HBEC) for TLR9 protein. 
Lane 1,2,3,4 different concentration of protein samples and lane 5 represents the protein 
marker in kDa. 
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Figure 5 representing the Western blot results of the HBECs induced with LPS. 
 
Lanes 2, 3, 4 representing the different concentration of the protein samples and lane 
1 representing the marker for TLR-9 
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